CTOs on the Move

Finexio

www.finexio.com

 
Finexio is the only platform designed to optimize and monetize your AP payments. Join the 50,000+ companies making payments on our platform.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.finexio.com
  • 55, E 3rd Ave
    San Mateo, CA USA 94401
  • Phone: 407.627.0600

Executives

Name Title Contact Details
Josh Miner
Director: Risk and Compliance Profile
Alex Reznik
Chief Technology Officer Profile
Sasan Hamidi
Chief Information Security Officer Profile

Funding

Finexio raised $23M on 10/14/2020

Similar Companies

Digital Webgroup

Digital Webgroup is a Tucson, AZ-based company in the Software and Internet sector.

JigSpace

Explore and create interactive, 3D knowledge for anything. We are on a mission to let anyone create, share and present their knowledge and products with spatial computing and AR technology.

GroupSoft

GroupSoft is a New York, NY-based company in the Software and Internet sector.

Support.com

Support.com, Inc. (NASDAQ: SPRT) is a leading provider of tech support and turnkey support center services, the maker of Support.com® Cloud software and services, and the producer of SUPERAntiSpyware® anti-malware products. Support.com`s services and products help leading brands deepen their customer relationships by delivering a fantastic customer support experience, which leads to happier customers, greater brand loyalty, and growing revenues. Consumers want technology that works, and Support.com helps them get the most from their technology.

Perthera

Perthera, Inc. is a service company that helps guide patients and their physicians to the best cancer treatment options available by bridging the gap between molecular testing and patient therapy. We provide a more complete view of the molecular pathways driving advanced stage cancer than any other company. By combining genomics, proteomics and clinical history, Perthera delivers a comprehensive molecular analysis of a patient`s tumor and identifies the best available FDA approved therapies and clinical trials for each individual patient.